Skip to main content

Table 2 Treatment outcomes and exposure doses

From: Fentanyl compared to buprenorphine for atrial fibrillation ablation analgesia and sedation: a retrospective cross-sectional study

Ā 

Buprenorphine

(nā€‰=ā€‰46)

Fentanyl

(nā€‰=ā€‰47)

p value

Recurrence of AF No. of patients (percentage of patients)

10 (21.7%)

14 (29.8%)

0.48

Complications No. of patients (percentage of patients)

0 (0%)

1 (2.1%)a

1.00

Cumulative DAP (fluoroscopy) (mGycm2) median (min-max)

22,298.5 (9749ā€“188,652)

25,100.0 (8750ā€“95,081)

0.20

Cumulative DAP (exposure) (mGycm2) median (min-max)

3779 (109ā€“22,622)

3260 (166ā€“11,013)

0.38

Cumulative total air kerma (mGy) median (min-max)

286.4 (95.3ā€“2192.4)

268.5 (84.9ā€“1105.0)

0.51

  1. a Pseudoaneurysm
  2. AF atrial fibrillation, DAP dose area product